Cabaletta Bio Inc.

NASDAQ: CABA · Real-Time Price · USD
1.71
0.06 (3.64%)
At close: Aug 15, 2025, 3:59 PM
1.71
0.00%
After-hours: Aug 15, 2025, 07:52 PM EDT

Cabaletta Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.64M 1.64M 1.64M 4.01M 4.01M 4.01M 4.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.2M 2.15M 2.06M 1.58M 1.51M 1.92M 1.52M 4.05M 4.06M 3.46M 3.68M 1.05M 912K 836K 733K 499K 278K 116K
Gross Profit
-558K -516K -424K 2.43M 2.5M 2.09M 2.49M -4.05M -4.06M -3.46M -3.68M -1.05M -912K -836K -733K -499K -278K -116K
Operating Income
-149.87M -134.25M -125.14M -114.5M -100.12M -85.73M -74.66M -67.82M -60.93M -58.1M -54.14M -51.73M -51.52M -49.6M -46.31M -41.75M -38.6M -35.65M
Interest Income
7.26M 8.53M 10.03M 10.34M 10.14M 8.87M 6.99M 5.33M 3.47M 2.21M 1.16M 559K 211K 67K 24K 40K 60K 94K
Pretax Income
-144.29M -126.76M -115.86M -104.16M -89.98M -76.87M -67.67M -62.48M -57.46M -55.88M -52.98M -51.17M -51.3M -49.53M -46.29M -41.71M -38.54M -35.56M
Net Income
-144.29M -126.76M -115.86M -104.16M -89.98M -76.87M -67.67M -61.67M -56.3M -54.57M -51.61M -50.62M -51.1M -49.48M -46.29M -41.71M -38.54M -35.56M
Selling & General & Admin
31.79M 30.37M 27.94M 24.7M 22.82M 20.06M 18.9M 17.4M 16.08M 15.53M 14.84M 14.91M 14.74M 14.49M 13.82M 13.4M 12.77M 12.34M
Research & Development
118.48M 104.27M 97.2M 89.08M 76.57M 64.94M 55.42M 50.42M 44.85M 42.56M 39.3M 36.82M 36.77M 35.11M 32.49M 28.35M 25.83M 23.31M
Other Expenses
-393K -393K -393K 336K 336K 336K 336K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
149.87M 134.25M 124.75M 114.11M 99.73M 85.34M 74.66M 67.82M 60.93M 58.1M 54.14M 51.73M 51.52M 49.6M 46.31M 41.75M 38.6M 35.65M
Interest Expense
1.61M 1.04M 748K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
393K 393K n/a -729K -729K -729K -336K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
149.87M 134.25M 125.14M 114.5M 100.12M 85.73M 74.66M 67.82M 60.93M 58.1M 54.14M 51.73M 51.52M 49.6M 46.31M 41.75M 38.6M 35.65M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -813K -1.16M -1.31M -1.37M -554K -203K -53K n/a n/a n/a n/a
Shares Outstanding (Basic)
61.88M 49.52M 50.13M 48.94M 48.94M 49.3M 44.44M 43.96M 39.17M 33.59M 29.45M 29.01M 28.99M 28.96M 28.34M 25.85M 20.42M 19.19M
Shares Outstanding (Diluted)
61.88M 49.47M 50.2M 49.47M 49.45M 49.3M 44.44M 43.96M 39.17M 35.45M 29.45M 29.01M 28.99M 28.96M 28.34M 25.85M 24.73M 23.76M
EPS (Basic)
-2.74 -2.57 -2.34 -2.16 -1.9 -1.71 -1.66 -1.7 -1.71 -1.78 -1.78 -1.76 -1.83 -1.94 -2 -1.91 -1.82 -1.62
EPS (Diluted)
-2.73 -2.56 -2.34 -2.16 -1.91 -1.72 -1.63 -1.67 -1.68 -1.75 -1.78 -1.76 -1.83 -1.84 -1.8 -1.71 -1.62 -1.52
EBITDA
-137.14M -122.9M -113.41M -112.92M -98.61M -84.28M -73.23M -66.37M -59.47M -56.77M -52.96M -50.68M -50.6M -48.76M -45.58M -41.14M -38.13M -35.26M
EBIT
-137.01M -122.73M -115.12M -114.5M -100.12M -85.73M -74.66M -67.82M -60.93M -58.1M -54.14M -51.73M -51.52M -49.6M -46.31M -41.75M -38.6M -35.65M
Depreciation & Amortization
1.84M 1.8M 1.71M 1.58M 1.51M 1.92M 1.89M 4.42M 4.42M 3.83M 3.68M 1.05M 912K 836K 733K 609K 478K 394K